Akademisyen
MUZAFFER UĞRAKLI
DOKTOR ÖĞRETİM ÜYESİ
NECMETTİN ERBAKAN ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 22
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
6
Q2
12
Q3
11
Q4
4
WoS (JCR)
Q1
9
Q2
4
Q3
9
Q4
10
TR Index
2
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
4
Ort. yüzdelik
53.8%
Üst %1 payı
0.0%
Üst %10 payı
11.4%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 4.2%
- 2026 Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group YÖKSİS SJR Q2 JCR Q3 OpenAlex 10.9%
- 2026 Integrated Inflammatory and Nutritional Biomarkers in Metastatic Renal Cell Carcinoma Treated with Second- or Later-Line Nivolumab: A Retrospective Cohort Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 81.7%
- 2026 Evaluation of the Relationship Between Prognostic Nutritional Index and Survival in Operated Stage II and III Colorectal Cancer Patients Receiving Adjuvant Chemotherapy YÖKSİS OpenAlex 87.4%
- 2025 Can erythrodermic psoriasis be considered a paraneoplastic syndrome in patients with metastatic occult gastric cancer? YÖKSİS SJR Q4 JCR Q4 OpenAlex 4.2%
- 2025 Gemcitabine-related fatal cholestatic hepatitis YÖKSİS SJR Q4 JCR Q4 OpenAlex 53.1%
- 2025 Palbociclib in liposarcoma: real-world multicenter data from the Turkish Oncology Group (TOG) YÖKSİS SJR Q3 JCR Q3 OpenAlex 27.5%
- 2024 Anthracycline-Induced Hepatitis B Reactivation in Solid Organ Cancers: A Multicenter Study YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 75.7%
- 2024 Comparison of the second-line treatment efficacy in advanced gastric cancer patients previously treated with taxane-based triplet chemotherapy: a Turkish Oncology Group Study YÖKSİS SJR Q2 JCR Q2 OpenAlex 13.1%
- 2023 Major and minor salivary gland cancers: A multicenter retrospective study YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.5%
- 2023 Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy YÖKSİS SJR Q2 JCR Q2 OpenAlex üst %10 OpenAlex 94.2%
- 2023 Could the concomitant use of beta blockers with bevacizumab improve survival in metastatic colon cancer? YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.1%
- 2023 The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study YÖKSİS SJR Q1 JCR Q3 OpenAlex 50.0%
- 2023 Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group YÖKSİS SJR Q1 JCR Q1 OpenAlex 87.6%
- 2022 Crizotinib efficacy and safety in patients with advanced NSCLC harboring MET alterations: A real-life data of Turkish Oncology Group YÖKSİS SJR Q3 JCR Q3 OpenAlex 67.0%
- 2022 Ribociclib-Induced Acute Pancreatitis in Metastatic Breast Cancer YÖKSİS OpenAlex 14.9%
- 2022 A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy YÖKSİS SJR Q3 JCR Q4 OpenAlex 40.8%
- 2021 Pazopanib-associated secondary adrenal insufficiency in a patient with malignant solitary fibrous tumor YÖKSİS SJR Q3 JCR Q4 OpenAlex 46.5%
- 2021 Pneumonitis associated with Trastuzumab emtansine in a patient with metastatic breast cancer YÖKSİS SJR Q3 JCR Q4 OpenAlex 66.8%
- 2021 The Impact of the COVID-19 Pandemic on Follow-Up and Management of Cancer Patients YÖKSİS SJR Q4 OpenAlex 46.2%